KY02111 promotes differentiation by inhibiting WNT signaling in hPSCs.
KY02111 induces cardiomyocytes expressed the cardiac markers, αMHC, NKH2.5, and HCN4.
KY02111 (1-10 μM; 12 hours, 24 hours) reduces WNT signaling in both IMR90-1 cells and HEK293 cells in a dose-dependent manner.
KY02111 treatment with WNT signaling modulators produces robust cardiac differentiation of hPSCs in a xeno-free, defined medium, devoid of serum and any kind of recombinant cytokines and hormones, such as BMP4, Activin A, or insulin.